Back to MW MARSHALL WACE, LLP

SANASANA
Showing 7 of 14 quarters

Position history for MWMARSHALL WACE, LLP's holdings in SANA BIOTECHNOLOGY INC

MARSHALL WACE, LLP holds 2.9M shares of SANA (SANA BIOTECHNOLOGY INC), worth $10.2M as of 2026-Q2. The position was increased (+341.2% shares). SANA represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$10.2M

Current Shares

2.9M

Total Value Change

+$8.6M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.9M
+341.2%
$10.2M0.0%$3.49
45
2026-Q1
Increased
664,457
+648.4%
$1.9M0.0%$3.93
42
2025-Q4
New
88,788
-
$361,3660.0%$4.08
33
2025-Q2
Exited
0
-100.0%
$00.0%$2.81
0
2025-Q1
Increased
211,227
+890.6%
$354,8610.0%$1.71
38
2024-Q4
Decreased
21,322
-94.6%
$34,7550.0%$1.61
0
2024-Q3
Increased
393,681
+109.7%
$1.6M0.0%$4.28
41

Other major holders of SANA: CANADA PENSION PLAN INVESTMENT BOARD, BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used